Biography
Dr. Altman graduated summa cum laude from the CUNY Hunter College Thomas Hunter Special Honors Program. She received her medical degree from the Rutgers New Jersey Medical School, where she was a member of the Alpha Omega Alpha Honor Society. She completed her dermatology residency at Northwestern University and Columbia University and a fellowship in dermatopathology at New York University. Dr. Altman served as Chief of Dermatology at Newark Beth Israel Medical Center in Newark, NJ from 2000 to 2010. Her interests include complex medical dermatology, dermatopathology, clinical research, teledermatology, inpatient/hospitalist dermatology, psoriasis, atopic dermatitis, transplant dermatology, oncodermatology, cutaneous T cell lymphoma, drug reactions, alopecia, skin cancer, vitiligo, collagen vascular diseases, vulvovaginal diseases, hidradenitis suppurativa, surgical dermatology, search engine optimization, social media, and teaching residents and medical students.
Dr. Altman is a board-certified dermatologist and is a member of seventeen regional, national and international dermatology societies and serves as President of the New Mexico Dermatological Society. She is on the editorial boards of the Journal of the American Academy of Dermatology (Associate Editor) and the American Journal of Clinical Dermatology. She is the author or coauthor of a number of medical articles, posters, abstracts and textbook chapters.
Areas of Specialty
Dermatology
Achievements & Awards
Professional Recognition, Honors, Awards
UNMH Procedural Consultant Award 2019
Nominated for a UNMH Stellar Consultant Award 2018
New Jersey Top Doctor, New Jersey Magazine 2007, 2017
HealthTap Summer Awards for Most Influential Doctor in Morristown Region, Thought Leader in Morristown Region, Top Dermatologist in New Jersey (third place), Top Doctor Morristown Region 2013
Super Doctor Award, Millburn-Short Hills, NJ 2013
Top Doctor, RealSelf.com 2011
Dermatology Blogger, Medscape 2011-2014
Gender
Female
Languages
- English
Research
Principal Investigator, PRN1008 in pemphigus vulgaris PEGASUS trial, 2020
Principal Investigator, bimekizumab in hidradenitis suppurativa, HS0003 and HS0004 trials, 2020
Courses Taught
Invited Lectures
Altman, EM. Grand Rounds UNM Neurology “Skin manifestations of movement disorders.” (March 13, 2020)
Floyd Silva MS-1, Hillary Elwood MD, Stephanie Stepenaskie MD, Emily Altman MD. Linking Up in the Skin. New Mexico Dermatological Society Meeting (February 21, 2020).
Maryam Sayah, Catherine Tchanque-Fossuo, Shelly Stepenaskie, Emily Altman. Abstract #1048-000335 Purpura Fulminans with Partial Features of Toxic Epidermal Necrolysis: A Potential Diagnostic Pitfall, poster presentation at the 56th Annual Meeting of the American Society of Dermatopathology (October 2019)
Catherine Tchanque-Fossuo, Hillary Elwood, Emily Altman. A Painfully Grueling Sore. New Mexico Dermatological Society presentation (February 22, 2019)
Randy Ko, Shelly Stepenaskie, Emily Altman, Loren Zech. Rapidly progressing telangiectasias in a young woman. New Mexico Dermatological Society presentation (February 22, 2019)
Mary Logue, Shelly Stepenaskie, Emily Altman. Ten of TEN: the story of Dermatology consults at UNM, 2017-2018. New Mexico Dermatological Society presentation (February 22, 2019)
Emily Altman. Dermatologic Manifestations of Lepromatous Leprosy. Infectious Diseases Grand Rounds presentation, University of New Mexico SOM (February 14, 2019)
Altman, EM. Grand Rounds UNM Infectious Diseases “Infection or not.” (February 7, 2019)
Runnels, J et al. Using telemedicine to screen for skin cancer in rural New Mexico: a societal cost-benefit analysis. Poster and presentation. University of New Mexico Research Day (2018)
Emily Altman. Causes of pruritus in a patient with Sezary syndrome. New Mexico Dermatological Society presentation (April 6, 2018)
Emily Altman. New Rash in a Heart Transplant Patient. Annual Walter Burgdorf Conference/New Mexico Dermatological Society presentation (October 13, 2017)
Research and Scholarship
Principal Investigator, PRN1008 in pemphigus vulgaris PEGASUS trial, 2020
Principal Investigator, bimekizumab in hidradenitis suppurativa, HS0003, HS0004 and HS0005 trials, 2020